Nicholson, T.; Ingram, P.; Barman, P.; Murray, I. A.
April 2004
Gut;Apr2004 Supplement 3, Vol. 53, pA22
Academic Journal
This article presents information on PPIs, TTOs and NICE guidelines with the aim to reduce prescribing costs. Cornwall has the highest prescribing costs for PPIs in England and Wales. NICE has produced guidelines for cost effective PPI prescribing including treatment plans for dose and duration of use and use of most cost effective drugs. The county has a joint formulary with lansoprazole and rabeprazole chosen as first line agents on the basis of cost. This audit demonstrated that PPIs were being initiated in secondary care without obvious indication.


Related Articles

  • Controlling Spending for Prescription Drugs. Altman, Stuart H.; Parks-Thomas, Cindy // New England Journal of Medicine;3/14/2002, Vol. 346 Issue 11, p855 

    Editorial. Focuses on the cost of prescription drugs in the United States. Problems with the cost of drugs for those who do not have health insurance; Cost of drugs for the elderly; Study in this issue by Lewis et al on discount drug programs for the elderly; How improving the affordability of...

  • Is the growth in our drug tab sustainable? Schondelmeyer, Stephen // Drug Topics;3/19/2007, Vol. 151 Issue 6, p83 

    The article presents an opinion on prescription expenditures, number of prescriptions, average prescription price, annual prescription use per person, and annual prescription expenditures per person in the U.S. Prescription drugs have increased in costs and utilization between the nineteen...

  • Short-term Rx cuts could lead to long-term cost increases.  // Westchester County Business Journal;6/10/2002, Vol. 41 Issue 23, p20 

    Talks about the impact of prescription drug on health care cost increases. Factors that contributed to rising prescription drug costs; Steps that employers should consider to mitigate rising health care costs.

  • Healthcare expenditure on the up in France, Spain.  // PharmacoEconomics & Outcomes News;5/6/2006, Issue 502, p10 

    The article reports on an increase in the spending on healthcare and pharmaceuticals in France and Spain. The reasons for the rise in healthcare expenditure in France are cited. The percentage increase in the average prescription price in Spain is mentioned. However, the legislation to curb...

  • Prescribing data shows slowdown in drug spending. Polak, Monika // GP: General Practitioner;5/3/2004, p5 

    The increase in prescribing costs has slowed down, according to data from the Prescription Pricing Authority (PPA) published last week. The PPA prescribing cost analysis for 2003 showed that almost 650 million prescription items were dispensed in 2003, costing just over pounds 7.51 billion....

  • The high cost of medicines in Ireland. Tilson, Lesley; McGowan, Bernadette; Bennett, Kathleen; Barry, Michael // European Journal of Health Economics;Dec2004, Vol. 5 Issue 4, p341 

    This study compared the prices of prescription medicines in Ireland to those in other countries to determine potential cost savings on the largest community drug scheme if an alternative pricing mechanism were adopted. The analysis covered a sample of 39 drugs (44.8% of the total ingredient...

  • WHY YOU PAY LESS FOR PILLS. Max, Sarah // Money;Jun2009, Vol. 38 Issue 6, p20 

    The article presents several charts regarding the prices of prescription medications.

  • The Influence of Wholesale Discounts and Other Factors on Prescription Ingredient Costs. Gagnon, Jean P.; Rodowskas, Jr., Christopher A. // American Journal of Public Health;Oct1974, Vol. 64 Issue 10, p969 

    This study determines the actual prescription ingredient costs for sample prescriptions from a number of pharmacies and evaluates the relationships of annual prescription volume, source of purchase, drug wholesale monthly discounts, and chain warehouse costs on a prescription's ingredient cost.

  • Controlling Drug Costs. Kimmey, James R. // American Journal of Public Health;Jun1972, Vol. 62 Issue 6, p755 

    The author reflects on the importance of controlling the cost of drugs. He argues that physician oftentimes prescribe incompatible drugs to their patients because of tendentious promotion and insufficient contact with fellow physicians. He suggests that a medical policy should be carried out to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics